InvestorsObserver
×
News Home

Will Quest Diagnostics Inc (DGX) Stay at the Bottom of the Healthcare Sector?

Thursday, November 30, 2023 03:25 PM | InvestorsObserver Analysts

Mentioned in this article

Will Quest Diagnostics Inc (DGX) Stay at the Bottom of the Healthcare Sector?

A rating of 24 puts Quest Diagnostics Inc (DGX) near the top of the Healthcare sector according to InvestorsObserver. Quest Diagnostics Inc's score of 24 means that it ranks higher than 24% of stocks in the sector. In addition, its overall score of 40 ranks it higher than 40% of all stocks.

Overall Score - 40
DGX has an Overall Score of 40. Find out what this means to you and get the rest of the rankings on DGX!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Quest Diagnostics Inc Stock Today?

Quest Diagnostics Inc (DGX) stock has risen 1.2% while the S&P 500 is down -0.09% as of 3:19 PM on Thursday, Nov 30. DGX has gained $1.62 from the previous closing price of $135.30 on volume of 417,176 shares. Over the past year the S&P 500 is higher by 11.43% while DGX is down -9.82%. DGX earned $6.67 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 20.52. Click Here to get the full Stock Report for Quest Diagnostics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App